Ruxolitinib vs triamcinolone -
Topical tofacitinib for LPP/FFA -
Locus of control in AD -
Low-dose naltrexone for LPP/FFA -
Alternative/complementary treatments for HSV -
Want to donate to the cause? Do so here!
Donate to the podcast: uofuhealth.org/dermasphere
Check out our video content on YouTube:
www.youtube.com/@dermaspherepodcast
and VuMedi!: www.vumedi.com/channel/dermasphere/
The University of Utah's Dermatology
ECHO: physicians.utah.edu/echo/dermatology-primarycare -
Connect with us!
- Web: dermaspherepodcast.com/ - Twitter: @DermaspherePC
- Instagram: dermaspherepodcast
- Facebook: www.facebook.com/DermaspherePodcast/
- Check out Luke and Michelle’s other podcast,
SkinCast! healthcare.utah.edu/dermatology/skincast/ Luke and Michelle report no significant conflicts of interest… BUT check out our
friends at:
- Kikoxp.com (a social platform for doctors to share knowledge)
- www.levelex.com/games/top-derm (A free dermatology game to learn
more dermatology!